Chembio Diagnostics Inc. (CEMI)

Business: Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases.

IPO Date: 18-Oct-2000

Pres, CEO & Director: Mr. Richard L. Eberly

Exec. VP and Chief Scientific & Technology Officer: Mr. Javan Esfandiari

Listing: NASDAQ: CEMI

Country: United States

Headquarters: Hauppauge, NY

Website: https://chembio.com

Market cap: $19.20 Mln

Revenue (TTM): $53.23 Mln

Earnings (TTM): $-38.19 Mln

Cash: $24.40 Mln

Total Debt: $25.81 Mln

Insider's Holding: 1.31%

Liquidity: Low

52 Week range: $0.42 - 7.34

Shares outstanding: 30,221,900

10 Years Aggregate:

• CFO: $-81.34 Mln
• EBITDA: $-84.52 Mln
• Net Profit: $-102.75 Mln